Article
Genetic heterogeneity in breast cancer: the road to personalized medicine?
BMC medicine - 18 Jun 2013
Baird Richard D, Caldas Carlos
Abstract excerpt
More women die from breast cancer across the world today than from any other type of malignancy. The clinical course of breast cancer varies tremendously between patients. While some of this variability is explained by traditional clinico-pathological factors (including patient age, tumor stage, histological grade and estrogen receptor status), molecular profiling studies have defined breast cancer subtypes with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
